OBALON THERAPEUTICS INC | Bonus & Incentive Agreements | Business Contracts

ReShape Lifesciences Inc. 2022 Equity Incentive Plan (Filed With SEC on December 20, 2022)

Retention Bonus Agreement, dated August 2, 2022, by and between the Company and Thomas Stankovich (Filed With SEC on August 2, 2022)

Form of Stock Option Grant Notice and Stock Option Agreement under ReShape Lifesciences Inc.s Second Amended and Restated 2003 Stock Incentive Plan (Filed With SEC on March 30, 2021)

Second Amended and Restated 2003 Stock Incentive Plan of ReShape Lifesciences Inc., as amended on May 23, 2018 (Filed With SEC on March 30, 2021)

Amended and Restated 2016 Equity Incentive Plan and form award agreements thereunder (Filed With SEC on November 6, 2020)

Form of Restricted Stock Unit Award pursuant to the 2016 Equity Incentive Plan (Filed With SEC on February 27, 2020)

Form of Restricted Stock Unit Award Agreement (Share and Cash Settlement) pursuant to the 2016 Equity Incentive Plan (Filed With SEC on February 27, 2020)

First Amendment to 2016 Equity Incentive Plan (Filed With SEC on February 22, 2019)

Form of Restricted Stock Unit Award pursuant to the 2016 Equity Incentive Plan (Filed With SEC on February 22, 2019)

OBALON THERAPEUTICS INC (65) | Bonus & Incentive Agreements (9)